Cargando…

Targeting endothelial dysfunction and oxidative stress in Long-COVID

Detalles Bibliográficos
Autores principales:	Trimarco, Valentina, Izzo, Raffaele, Mone, Pasquale, Trimarco, Bruno, Santulli, Gaetano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467917/ https://www.ncbi.nlm.nih.gov/pubmed/36108875 http://dx.doi.org/10.1016/j.phrs.2022.106451

Ejemplares similares

Beneficial effects of Vitamin C and L-Arginine in the treatment of post-acute sequelae of COVID-19
por: Santulli, Gaetano, et al.
Publicado: (2022)

Endothelial dysfunction in long-COVID: New insights from the nationwide multicenter LINCOLN Study
por: Trimarco, Valentina, et al.
Publicado: (2022)

Role of endothelial miR-24 in COVID-19 cerebrovascular events
por: Gambardella, Jessica, et al.
Publicado: (2021)

Therapeutic concordance improves blood pressure control in patients with resistant hypertension
por: Trimarco, Valentina, et al.
Publicado: (2023)

The therapeutic concordance approach reduces adverse drug reactions in patients with resistant hypertension
por: Trimarco, Valentina, et al.
Publicado: (2023)

Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis
por: Fiorentino, Giuseppe, et al.
Publicado: (2021)

Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.”
por: Fiorentino, Giuseppe, et al.
Publicado: (2022)

Choline supplements: An update
por: Kansakar, Urna, et al.
Publicado: (2023)

Beneficial effects of L-Arginine in patients hospitalized for COVID-19: New insights from a randomized clinical trial
por: Trimarco, Valentina, et al.
Publicado: (2023)

Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey
por: Izzo, Raffaele, et al.
Publicado: (2022)

Arginine and Endothelial Function
por: Gambardella, Jessica, et al.
Publicado: (2020)

L-Arginine Improves Cognitive Impairment in Hypertensive Frail Older Adults
por: Mone, Pasquale, et al.
Publicado: (2022)

The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events
por: Galasso, Gennaro, et al.
Publicado: (2010)

Hypertensive target organ damage predicts incident diabetes mellitus
por: Izzo, Raffaele, et al.
Publicado: (2013)

l-Arginine and COVID-19: An Update
por: Adebayo, Ayobami, et al.
Publicado: (2021)

Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the β adrenergic system
por: Santulli, Gaetano, et al.
Publicado: (2013)

Impaired mitochondrial calcium uptake caused by tacrolimus underlies beta-cell failure
por: Lombardi, Angela, et al.
Publicado: (2017)

Low mechano‐energetic efficiency is associated with future left ventricular systolic dysfunction in hypertensives
por: Manzi, Maria V., et al.
Publicado: (2022)

L-Arginine in diabetes: clinical and preclinical evidence
por: Forzano, Imma, et al.
Publicado: (2023)

Correction: L-Arginine in diabetes: clinical and preclinical evidence
por: Forzano, Imma, et al.
Publicado: (2023)

Sirolimus induces depletion of intracellular calcium stores and mitochondrial dysfunction in pancreatic beta cells
por: Lombardi, Angela, et al.
Publicado: (2017)

Adrenergic receptors and metabolism: role in development of cardiovascular disease
por: Ciccarelli, Michele, et al.
Publicado: (2013)

Vitamin C and Cardiovascular Disease: An Update
por: Morelli, Marco B., et al.
Publicado: (2020)

Atrial fibrillation and microRNAs
por: Santulli, Gaetano, et al.
Publicado: (2014)

miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells
por: Mone, Pasquale, et al.
Publicado: (2021)

miR-24 targets SARS-CoV-2 co-factor Neuropilin-1 in human brain microvascular endothelial cells: Insights for COVID-19 neurological manifestations
por: Mone, Pasquale, et al.
Publicado: (2021)

Determinants of improvement of left ventricular mechano-energetic efficiency in hypertensive patients
por: Lembo, Maria, et al.
Publicado: (2022)

Trafficking GRK2: Cellular and Metabolic consequences of GRK2 subcellular localization.
por: Sorriento, Daniela, et al.
Publicado: (2014)

Sortilin drives hypertension by modulating sphingolipid/ceramide homeostasis and by triggering oxidative stress
por: Varzideh, Fahimeh, et al.
Publicado: (2022)

Insufficient Control of Blood Pressure and Incident Diabetes
por: Izzo, Raffaele, et al.
Publicado: (2009)

Adrenergic Mechanism in the Control of Endothelial Function
por: Sorriento, Daniela, et al.
Publicado: (2011)

Effects of a New Combination of Nutraceuticals with Morus alba on Lipid Profile, Insulin Sensitivity and Endotelial Function in Dyslipidemic Subjects. A Cross-Over, Randomized, Double-Blind Trial
por: Trimarco, Valentina, et al.
Publicado: (2015)

Parathyroid Hormone Causes Endothelial Dysfunction by Inducing Mitochondrial ROS and Specific Oxidative Signal Transduction Modifications
por: Gambardella, Jessica, et al.
Publicado: (2018)

miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections
por: Kansakar, Urna, et al.
Publicado: (2022)

A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFκB activity
por: Sorriento, Daniela, et al.
Publicado: (2009)

The Amino-Terminal Domain of GRK5 Inhibits Cardiac Hypertrophy through the Regulation of Calcium-Calmodulin Dependent Transcription Factors
por: Sorriento, Daniela, et al.
Publicado: (2018)

Carotid Atherosclerosis Predicts Blood Pressure Control in Patients With Hypertension: The Campania Salute Network Registry
por: Mancusi, Costantino, et al.
Publicado: (2022)

Hypertension-mediated organ damage involving multiple sites is an independent risk factor for cardiovascular events
por: Lembo, Maria, et al.
Publicado: (2023)

A single blind, multicenter, randomized controlled trial to evaluate the effectiveness and cost of a novel nutraceutical (LopiGLIK(®)) lowering cardiovascular disease risk
por: Manfrin, Andrea, et al.
Publicado: (2018)

miR-4432 Targets FGFBP1 in Human Endothelial Cells
por: Avvisato, Roberta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3uqdf67mfp1lnqc3n0bt73imce